The centerpiece of the company's participation is a scientific symposium scheduled for October 17, titled From Benchtop to Bedside. Led by Fesarius founder and Chief Medical Officer Dr. Jason Spector, the session will dissect the microarchitecture of the dual-density collagen template. Joining him is Dr. Brendan MacKay of the Texas Tech University Health Sciences Center, who will provide insights into the clinical application of the technology for vascularization and tissue formation.

Beyond the scientific presentations, Fesarius is deepening its ties to the investment community. President and CEO Tom Roueche will join an expert panel hosted by ASPS Ventures at the Hilton Hotel to discuss the intersection of plastic surgery and medical technology development. As the fund's inaugural investment, the company aims to demonstrate how its hydrogel platform addresses persistent gaps in dermal repair. Attendees can examine the technology firsthand at booth #1920 throughout the four-day event.